Dr. De Oliveira is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
UCLA Department of Pediatrics Hematology/Oncology
10833 Le Conte Ave., MDCC A2-410
Los Angeles, CA 90095Phone+1 310-825-6708Fax+1 310-825-6708- Is this information wrong?
Summary
- I have been working in Pediatric Hematology/Oncology since 1999, in Brazil, and decided to move to the US to start a Translational Research career.
My long term goals are:
1) bring Cancer Immunotherapy and Cellular Therapy concepts to standard
clinical practice to improve patient care and survival outcomes.
2) decrease disparities and increase access to healthcare to minorities.
Clinical Expertise
- Non-Hodgkin lymphoma, Thrombophilias, Hematopoietic stem cell transplantation, General pediatrics, Leukemia, Pediatric bone marrow transplantation, Pediatric hematopoietic stem cell transplantation, Pediatric red blood cell hematology, Adoptive immunotherapy
Education & Training
- Children's Hospital Los AngelesFellowship, Pediatric Hematology/Oncology, 2007 - 2010
- Woodhull Medical and Mental Health CenterResidency, Pediatrics, 2004 - 2007
- Univ Sao Paulo- Fac MedClass of 1995, MD
Certifications & Licensure
- CA State Medical License 2007 - 2025
- American Board of Pediatrics Pediatrics
- American Board of Pediatrics Pediatric Hematology-Oncology
Awards, Honors, & Recognition
- 1K23 CA222659-01 NIH NCI
- ASH Scholar Award American Society of Hematology
- Hyundai Hope On Wheels Scholar Award Hyundai Hope On Wheels
- Join now to see all
Clinical Trials
- A Study of the Efficacy and Safety of Hematopoietic Stem Cells Transduced With Lenti-D Lentiviral Vector for the Treatment of Cerebral Adrenoleukodystrophy (CALD) Start of enrollment: 2013 Aug 21
- Long-term Follow-up of Participants With Cerebral Adrenoleukodystrophy Who Were Treated With Lenti-D Drug Product Start of enrollment: 2016 Jan 22
- Phase I/II Trial of Lentiviral Gene Transfer for SCID-X1 With Low Dose Targeted Busulfan Conditioning Start of enrollment: 2018 Jan 19
- Join now to see all
Publications & Presentations
PubMed
- 9 citationsPost-Transplantation Cyclophosphamide Is Associated with an Increase in Non-Cytomegalovirus Herpesvirus Infections in Patients with Acute Leukemia and Myelodysplastic ...Anurag K. Singh, Christopher E. Dandoy, Min Chen, Soyoung Kim, Carolyn Mulroney, Mohamed A. Kharfan-Dabaja, Siddhartha Ganguly, Richard T. Maziarz, Christopher G. Kana...> ;Transplantation and Cellular Therapy. 2021 Sep 26
- 8 citationsImpact of cytogenetic abnormalities on outcomes of adult Philadelphia-negative acute lymphoblastic leukemia after allogeneic hematopoietic stem cell transplantation: a...Aleksandr Lazaryan, Michelle Dolan, Mei-Jie Zhang, Hai-Lin Wang, Mohamed A Kharfan-Dabaja, David I Marks, Nelli Bejanyan, Edward Copelan, Navneet S Majhail, Edmund K W...> ;Haematologica. 2021 Aug 1
- 80 citationsAutologous Ex Vivo Lentiviral Gene Therapy for Adenosine Deaminase Deficiency.Donald B. Kohn, Claire Booth, Kit L. Shaw, Jinhua Xu-Bayford, Elizabeth Garabedian, Valentina Trevisan, Denise A. Carbonaro-Sarracino, Kajal Soni, Dayna Terrazas, Kati...> ;The New England Journal of Medicine. 2021 May 11
- Join now to see all
Journal Articles
- Same sibling marrow following cord allogeneic transplantation as therapy for second relapse acute promyelocytic leukemia in a pediatric patient.De Oliveira SN, Kao RL, Pham A, Smith LT, Kempert P, Moore TB., Pediatric Transplantation, 3/1/2016
- Beta-globin gene transfer to human bone marrow for sickle cell diseaseRomero Z, Urbinati F, Geiger S, Cooper AR, Wherley J, Kaufman ML, Hollis RP, Ruiz de Assin R, Senadheera S, Sahagian A, Jin X, Gellis A, Wang X, Gjertson D, De Oliveir..., J Clin Invest, 1/1/2013
- Epidemiological evaluation of leprosy and leprosy health services in Ribeirao Preto City, Brazil, in 1992Oliveira, SN; Hennemann,GV; Ferreira,FLF; Azevedo,SA; Forster, AC, Medicina, 1/1/1996
Books/Book Chapters
Abstracts/Posters
- Dissecting the Immune Cell Progeny of CAR-Expressing Hematopoietic Stem Cells in a Humanized Mouse ModelSatiro N. De Oliveira, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
- Autologous hematopoietic stem cell gene therapy for cerebral adrenoleukodystrophy - Results of an international Phase 2/3 trialSatiro De Oliveira, Florian Eichler, Christine Duncan, Patricia L. Musolino, Paul J. Orchard, Adrian Thrasher, Myriam Armant, Colleen Dansereau, Troy C. Lund, Weston P..., 40th Annual Meeting of the Society for Inherited Metabolic Disorders (SIMD), San Diego, CA, 1/11/2018
- Isolated Testicular Recurrence of AML in Patients with Chronic GVHD more than One Year following Transplant.Dang B, Bowles LV, De Oliveira SN and Moore T, 30th Annual Meeting of the American Society of Pediatric Hematology/Oncology (ASPHO), Pediatric Blood & Cancer 64 Supplement, Montreal, Quebec, Canada, 1/26/2017
- Join now to see all
Lectures
- Engineering Precision Medicine to Increase Graft-Versus-Lymphoma Activity: Hematopoietic Stem Cells Modified with Chimeric Antigen Receptors2018 ASH Annual Meeting - San Diego, CA - 12/1/2018
- Treatment of Neuroblastoma with Natural Killer Cells Genetically Engineered to Target Tumor CellsLos Angeles, CA - 1/1/2018
- Humanized Mouse Models for Hematopoietic Stem Cell Research: Principles and Pitfalls1/1/2018
- Join now to see all
Professional Memberships
- Member
- Member
- Member
Other Languages
- Portuguese, Spanish
Hospital Affiliations
- Ronald Reagan UCLA Medical CenterLos Angeles, California
- UCLA Medical Center-Santa MonicaSanta Monica, California
- Mattel Childrens Hospital University of California Los AngelesLos Angeles, California
External Links
- Ucla Healthhttp://www.uclahealth.org/SatiroDeOliveira
- Linkedinhttps://www.linkedin.com/in/satiro-de-oliveira-m-d-251b603a/
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: